Cargando…

Different chemical proteomic approaches to identify the targets of lapatinib

The process of identifying the protein targets and off-targets of a biologically active compound is of great importance in modern drug discovery. Various chemical proteomics approaches have been established for this purpose. To compare the different approaches, and to understand which method would p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovačević, Tatjana, Nujić, Krunoslav, Cindrić, Mario, Dragojević, Snježana, Vinter, Adrijana, Hozić, Amela, Mesić, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980154/
https://www.ncbi.nlm.nih.gov/pubmed/36856014
http://dx.doi.org/10.1080/14756366.2023.2183809
_version_ 1784899858207866880
author Kovačević, Tatjana
Nujić, Krunoslav
Cindrić, Mario
Dragojević, Snježana
Vinter, Adrijana
Hozić, Amela
Mesić, Milan
author_facet Kovačević, Tatjana
Nujić, Krunoslav
Cindrić, Mario
Dragojević, Snježana
Vinter, Adrijana
Hozić, Amela
Mesić, Milan
author_sort Kovačević, Tatjana
collection PubMed
description The process of identifying the protein targets and off-targets of a biologically active compound is of great importance in modern drug discovery. Various chemical proteomics approaches have been established for this purpose. To compare the different approaches, and to understand which method would provide the best results, we have chosen the EGFR inhibitor lapatinib as an example molecule. Lapatinib derivatives were designed using linkers with motifs, including amino (amidation), alkyne (click chemistry) and the diazirine group (photo-affinity). These modified lapatinib analogues were validated for their ability to inhibit EGFR activity in vitro and were shown to pull down purified recombinant EGFR protein. In all of the approaches evaluated here, we identified EGFR as the main protein target from the lysate of immortalised cell line expressing EGFR, thus validating its potential use to identify unknown protein targets. Taken together, the results reported here give insight into the cellular activities of lapatinib.
format Online
Article
Text
id pubmed-9980154
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-99801542023-03-03 Different chemical proteomic approaches to identify the targets of lapatinib Kovačević, Tatjana Nujić, Krunoslav Cindrić, Mario Dragojević, Snježana Vinter, Adrijana Hozić, Amela Mesić, Milan J Enzyme Inhib Med Chem Research Paper The process of identifying the protein targets and off-targets of a biologically active compound is of great importance in modern drug discovery. Various chemical proteomics approaches have been established for this purpose. To compare the different approaches, and to understand which method would provide the best results, we have chosen the EGFR inhibitor lapatinib as an example molecule. Lapatinib derivatives were designed using linkers with motifs, including amino (amidation), alkyne (click chemistry) and the diazirine group (photo-affinity). These modified lapatinib analogues were validated for their ability to inhibit EGFR activity in vitro and were shown to pull down purified recombinant EGFR protein. In all of the approaches evaluated here, we identified EGFR as the main protein target from the lysate of immortalised cell line expressing EGFR, thus validating its potential use to identify unknown protein targets. Taken together, the results reported here give insight into the cellular activities of lapatinib. Taylor & Francis 2023-03-01 /pmc/articles/PMC9980154/ /pubmed/36856014 http://dx.doi.org/10.1080/14756366.2023.2183809 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Kovačević, Tatjana
Nujić, Krunoslav
Cindrić, Mario
Dragojević, Snježana
Vinter, Adrijana
Hozić, Amela
Mesić, Milan
Different chemical proteomic approaches to identify the targets of lapatinib
title Different chemical proteomic approaches to identify the targets of lapatinib
title_full Different chemical proteomic approaches to identify the targets of lapatinib
title_fullStr Different chemical proteomic approaches to identify the targets of lapatinib
title_full_unstemmed Different chemical proteomic approaches to identify the targets of lapatinib
title_short Different chemical proteomic approaches to identify the targets of lapatinib
title_sort different chemical proteomic approaches to identify the targets of lapatinib
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980154/
https://www.ncbi.nlm.nih.gov/pubmed/36856014
http://dx.doi.org/10.1080/14756366.2023.2183809
work_keys_str_mv AT kovacevictatjana differentchemicalproteomicapproachestoidentifythetargetsoflapatinib
AT nujickrunoslav differentchemicalproteomicapproachestoidentifythetargetsoflapatinib
AT cindricmario differentchemicalproteomicapproachestoidentifythetargetsoflapatinib
AT dragojevicsnjezana differentchemicalproteomicapproachestoidentifythetargetsoflapatinib
AT vinteradrijana differentchemicalproteomicapproachestoidentifythetargetsoflapatinib
AT hozicamela differentchemicalproteomicapproachestoidentifythetargetsoflapatinib
AT mesicmilan differentchemicalproteomicapproachestoidentifythetargetsoflapatinib